Key result
Dexmedetomidine added to ropivacaine accelerates motor block onset and prolongs analgesia without reducing anesthetic needs.
Why the study?
The effect of perineural dexmedetomidine on the onset time, quality, and duration of motor block with ropivacaine and its interaction with general anaesthesia had been equivocal and unreported.
Does adding dexmedetomidine to ropivacaine improve the characteristics of supraclavicular brachial plexus block and reduce general anaesthetic requirements in patients undergoing upper limb orthopaedic surgery?
RCT (n=36)
double blind
randomised
Does adding dexmedetomidine to ropivacaine improve the characteristics of supraclavicular brachial plexus block and reduce general anaesthetic requirements in patients undergoing upper limb orthopaedic surgery?
Adding dexmedetomidine to ropivacaine for supraclavicular block improves block onset and duration but does not reduce general anaesthetic requirements.
Accelerates onset and prolongs supraclavicular block with dexmedetomidine; extends RCT evidence for adjunct use without anaesthetic sparing.
BACKGROUND AND AIMS: The effect of perineural dexmedetomidine on the time to onset, quality and duration of motor block with ropivacaine has been equivocal and its interaction with general anaesthesia (GA) has not been reported. We assessed the influence of dexmedetomidine added to 0.5% ropivacaine on the characteristics of supraclavicular brachial plexus block and its interaction with GA. METHODS: In a randomised, double blind study, 36 patients scheduled for orthopaedic surgery on the upper limb under supraclavicular block and GA were divided into either R group (35 ml of 0.5% ropivacaine with 0.5 ml of normal saline [n - 18]) or RD group (35 mL of 0.5% ropivacaine with 50 μg dexmedetomidine [n - 18]). The onset time and duration of motor and sensory blockade were noted. The requirement of general anaesthetics was recorded. RESULTS: Both the groups were comparable in demographic characteristics. The time of onset of sensory block was not significantly different. The proportion of patients who achieved complete motor blockade was more in the RD group. The onset of motor block was earlier in group RD than group R (P < 0.05). The durations of analgesia, sensory and motor blockade were significantly prolonged in group RD (P < 0.00). The requirement of entropy guided anaesthetic agents was not different in both groups. CONCLUSIONS: The addition of dexmedetomidine to 0.5% ropivacaine improved the time of onset, quality and duration of supraclavicular brachial plexus block but did not decrease the requirement of anaesthetic agents during GA.
No takes yet. Share an insight, caveat, or question.
Gurajala et al. (2015) conducted an RCT in orthopaedic surgery on the upper limb (n=36). dexmedetomidine vs. normal saline was evaluated on onset time and duration of motor and sensory blockade (p=< 0.05). Adding dexmedetomidine to 0.5% ropivacaine for supraclavicular block accelerated motor block onset (P<0.05) and prolonged analgesia and block duration (P<0.00), without reducing anaesthetic needs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: